Studies on the urinary excretion of thromboxane B2 in Zellweger patients and control subjects: evidence for a major role for peroxisomes in the beta-oxidative chain-shortening of thromboxane B2.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1994-04-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0925-4439(94)90057-4PMID 8155738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peroxisomal degradation of leukotrienes by beta-oxidation from the omega-end.

  1991cited by this paper
• The inborn errors of peroxisomal beta-oxidation: a review.

  1990cited by this paper
• Beta-oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria.

  1988cited by this paper
• Peroxisomal chain-shortening of prostaglandin F2 alpha.

  1988cited by this paper
• Peroxisomal disorders in neurology.

  1988cited by this paper
• A sibship with a mild variant of Zellweger syndrome

  1987cited by this paper
• Chain-shortening of prostaglandin F2 alpha by rat liver peroxisomes.

  1987cited by this paper
• Beta-oxidation of very-long-chain fatty acids and their coenzyme A derivatives by human skin fibroblasts.

  1987cited by this paper
• Peroxisomal beta-oxidation of long-chain fatty acids possessing different extents of unsaturation.

  1987cited by this paper
• Chain-shortening of prostaglandin F2α by rat liver peroxisomes

  1987cited by this paper
• β-oxidation of very-long-chain fatty acids and their coenzyme A derivatives by human skin fibroblasts

  1987cited by this paper
• beta-Oxidation of polyunsaturated fatty acids by rat liver peroxisomes. A role for 2,4-dienoyl-coenzyme A reductase in peroxisomal beta-oxidation.

  1986cited by this paper
• In vitro formation of bile acids from di- and trihydroxy-5 beta-cholestanoic acid in human liver peroxisomes.

  1986cited by this paper
• Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.

  1984cited by this paper
• Separation of major prostaglandins, leukotrienes, and monoHETEs by high performance liquid chromatography.

  1983cited by this paper
• Formation of cholic acid from 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid by rat liver peroxisomes.

  1983cited by this paper
• Metabolism of very long-chain monounsaturated fatty acids (22:1) and the adaptation to their presence in the diet.

  1982cited by this paper
• Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites.

  1981cited by this paper
• Very long chain fatty acid oxidation in rat liver.

  1981cited by this paper
• Tetranor thromboxane B2 is the principal urinary catabolite formed after i.v. infusion of thromboxane B2 in the rat.

  1980cited by this paper
• Conversion of 3α,7α,12α‐trihydroxy‐5β‐cholestanoic acid into cholic acid by rat liver peroxisomes

  1980cited by this paper
• Conversion of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid into cholic acid by rat liver peroxisomes.

  1980cited by this paper
• The effect of clofibrate-feeding on hepatic fatty acid metabolism.

  1978cited by this paper
• Metabolism of thromboxane B2 in man. Identification of the major urinary metabolite.

  1977cited by this paper
• Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.

  1976cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper

• Deficiency of peroxisomal L-bifunctional protein (EHHADH) causes male-specific kidney hypertrophy and proximal tubular injury in mice

  2021cites this paper
• Peroxisomal L-bifunctional Protein Deficiency Causes Male-specific Kidney Hypertrophy and Proximal Tubular Injury in Mice

  2021cites this paper
• "Role of peroxisomes in human lipid metabolism and its importance for neurological development".

  2017cites this paper
• Downregulation of inflammatory markers by conjugated linoleic acid isomers in human cultured astrocytes

  2017cites this paper
• Peroxisomes in Humans: Metabolic Functions, Cross Talk with Other Organelles, and Pathophysiology of Peroxisomal Disorders

  2014cites this paper
• Peroxisomes in human health and disease: metabolic pathways, metabolite transport, interplay with other organelles and signal transduction.

  2013cites this paper
• A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers

  2011cites this paper
• Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism

  2010cites this paper
• Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism[S]

  2010cites this paper
• Functions and Dysfunctions of Peroxisomes in Fatty Acid α- and β-Oxidation

  2002cites this paper
• Functions and dysfunctions of peroxisomes in fatty acid alpha- and beta-oxidation. New insights.

  1999cites this paper
• Lipid metabolism in peroxisomes in relation to human disease.

  1998cites this paper
• Amelioration of radiation nephropathy by acetylsalicylic acid.

  1995cites this paper
• Measurement of peroxisomal fatty acid β-oxidation in cultured human skin fibroblasts

  1995cites this paper